Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trialsPublished 1y ago - iNFO ViCNN — An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday. Gantenerumab is part of a class of inj... More »
Second Shanghai Art Fair Closes Due to Covid, Banksy Work Appears in Ukraine, and More: Morning Links for November 14, 2022Published 1y ago - iNFO ViHere's what we're reading this morning. More »